Qorvo Gets FDA EUA for Omnia Rapid Covid-19 Antigen Testing
The Qorvo Omnia SARS-CoV-2 Antigen Test is authorized for the qualitative detection of nucleocapsid viral antigens from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of covid-19.